On this page
Debrancher deficiency (GSD IIIa)
This condition affects the ability to release glucose from glycogen stores, leading to low blood sugar and liver and muscle problems. It is typically diagnosed in infancy or early childhood and impacts approximately 1 in 100,000 people globally.
Available at Jeen Health
Clinical tests that include this
Overview
Debrancher deficiency, or GSD IIIa, is a type of glycogen storage disease. Glycogen is the body's main way of storing glucose, a type of sugar, for energy. It's like a reserve fuel tank, primarily located in the liver and muscles. In GSD IIIa, an enzyme needed to debranch glycogen is missing or doesn't work correctly. This means glycogen cannot be fully broken down into glucose when the body needs it, leading to various health issues.
The condition is present from birth, though symptoms may appear at different ages. It affects both males and females in equal measure. Managing GSD IIIa typically involves dietary adjustments and careful monitoring to prevent complications associated with impaired glycogen metabolism.
Symptoms & clinical features
The symptoms of Debrancher deficiency can vary, but commonly include problems related to low blood sugar (hypoglycaemia) and issues with the liver and muscles. In infancy or early childhood, affected individuals might experience an enlarged liver (hepatomegaly), which can sometimes lead to a swollen abdomen [PMID:33678486].
Muscle weakness (myopathy) can develop, gradually affecting everyday activities. Some individuals may also experience delays in physical development. Other signs can include elevated levels of certain fats (lipids) in the blood and issues with muscle tone, which might contribute to difficulties with movement [PMID:24765620].
Video: Genetics 101
Affected organs
Debrancher deficiency primarily affects the liver and muscles, as these are the main sites where glycogen is stored and broken down. The liver plays a crucial role in maintaining blood glucose levels, and its inability to properly release glucose from glycogen can lead to recurrent episodes of low blood sugar.
Muscles, including the heart muscle, also rely on glycogen for energy. Affected individuals might experience muscle weakness that can develop over time. In some cases, the heart muscle (cardiac muscle) can also be affected, potentially leading to specific heart problems.
Risks & severity
The severity of Debrancher deficiency can vary considerably between individuals. Some people might have relatively mild symptoms, while others face more significant health challenges. The lifetime risks associated with GSD IIIa can include progressive muscle weakness, liver complications such as cirrhosis in adulthood, and potential heart problems [PMID:24765620].
While the condition is present from birth, symptoms often become noticeable in infancy or early childhood. Low blood sugar episodes are typically more common in younger children. The disease course usually involves careful management throughout life to mitigate symptoms and prevent long-term complications.
Genetic causes
Debrancher deficiency is caused by pathogenic changes in the _AGL_ gene. This gene provides instructions for making an enzyme called glycogen debranching enzyme. This enzyme has two main jobs: it helps to move branches of glucose molecules in glycogen and then removes the final glucose molecule from these branches.
When the _AGL_ gene has a pathogenic variant, the glycogen debranching enzyme either isn't produced or doesn't work correctly. This means that glycogen, which has a highly branched structure, cannot be fully broken down. Instead, an abnormal, partially broken-down form of glycogen accumulates in cells, particularly in the liver and muscles, leading to the symptoms of GSD IIIa.
- AGL amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferaseThe AGL gene encodes an enzyme essential for breaking down glycogen, the body's stored form of glucose, playing a critical role in energy metabolism.
Inheritance pattern
Debrancher deficiency follows an autosomal recessive inheritance pattern. This means that an individual must inherit two pathogenic variants, one from each parent, to develop the condition. Parents who each carry one copy of the pathogenic gene variant are usually unaffected themselves because they have one working copy of the gene.
If both parents are carriers, there is a 25% chance with each pregnancy that their child will inherit two copies of the pathogenic variant and develop the condition. There is also a 50% chance the child will be a carrier like their parents, and a 25% chance the child will inherit two working copies of the gene and not be affected or a carrier.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
Diagnosing Debrancher deficiency typically involves a combination of clinical suspicion, biochemical tests, and genetic testing. If GSD IIIa is suspected, blood tests may show signs of low blood sugar, elevated liver enzymes, and high levels of certain fats. Liver biopsy, which examines tissue samples, can also show characteristic glycogen accumulation.
A definitive diagnosis is confirmed through genetic testing for pathogenic variants in the _AGL_ gene. This type of testing is available through the NHS Genomic Medicine Service (GMS), often initiated by a referral from a specialist paediatrician or metabolic consultant. The relevant NHS Genomic Test Directory R-codes would be used for this diagnostic pathway.
Management & lifestyle
While there is no cure for Debrancher deficiency, management focuses on alleviating symptoms and preventing complications. The primary aim is to maintain stable blood glucose levels and provide adequate nutrition. This often involves a specialised diet with frequent small meals, high in protein, and sometimes including uncooked cornstarch, which releases glucose slowly overnight [PMID:33678486].
Regular monitoring of liver function, muscle strength, and heart health is important. In the UK, individuals with GSD IIIa are typically managed by a multidisciplinary team, including metabolic specialists, dietitians, and hepatologists, as part of the NHS care pathway. Genetic counselling is also an important component of care, offering information and support to affected families.
UK care pathway
In the UK, individuals suspected of having genetic conditions like Debrancher deficiency are typically referred to specialist services within the NHS. This pathway often begins with a general practitioner (GP) referring to a paediatrician or a metabolic specialist. If a genetic condition is suspected, they may then be referred to a clinical genetics service.
Genetic testing for conditions such as GSD IIIa is provided through the NHS Genomic Medicine Service (GMS), using specific R-codes from the National Genomic Test Directory. Genetic counsellors play a vital role, providing information about the condition, inheritance patterns, and supporting families through the diagnostic and management process.
Frequently asked questions
What is glycogen and why is it important?
Glycogen is a complex sugar that your body makes from glucose. It's the primary way your body stores energy for future use, especially in the liver and muscles. When your blood sugar drops or your muscles need energy, glycogen is broken down into glucose to provide fuel.
How common is Debrancher deficiency?
Debrancher deficiency is considered a rare condition, affecting approximately 1 in every 100,000 people globally. Its exact prevalence can vary in different populations.
Can Debrancher deficiency affect the heart?
Yes, in some individuals, Debrancher deficiency can affect the heart muscle, leading to specific heart problems. Regular monitoring as part of ongoing medical care helps to detect and manage any potential cardiac involvement.
What kind of diet is recommended for GSD IIIa?
A specialised diet is often recommended, usually high in protein, with frequent small meals to prevent low blood sugar. Some people may be advised to consume uncooked cornstarch, which provides a slow release of glucose, especially during overnight fasting periods.
Is GSD IIIa the same as GSD IIIb?
GSD IIIa and GSD IIIb are both types of Debrancher deficiency caused by pathogenic variants in the _AGL_ gene. However, GSD IIIa affects both the liver and muscles, while GSD IIIb primarily affects only the liver. The underlying genetic problem is the same, but the clinical presentation can differ slightly.